Morgan Stanley Downgrades Elanco Animal Health to Equal-Weight, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has downgraded Elanco Animal Health from Overweight to Equal-Weight and reduced its price target from $17 to $15.

September 19, 2024 | 10:47 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has downgraded Elanco Animal Health from Overweight to Equal-Weight, reducing the price target from $17 to $15, indicating a less optimistic outlook.
The downgrade from Overweight to Equal-Weight by Morgan Stanley suggests a less favorable view on Elanco's stock performance. The reduced price target from $17 to $15 indicates expectations of lower future stock price, likely leading to a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100